APA (7th ed.) Citation

EK, B., TT, K., ST, d. B., & M, L. (2026). Reverse haplotyping: Taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington's disease. Journal of medical genetics, 63(7), 463. https://doi.org/10.1136/jmg-2026-111509

Chicago Style (17th ed.) Citation

EK, Bijlsma, Koopmann TT, de Bot ST, and Losekoot M. "Reverse Haplotyping: Taking Full Advantage of 25% Risk Testing for the 50% At-risk Parent in Huntington's Disease." Journal of Medical Genetics 63, no. 7 (2026): 463. https://doi.org/10.1136/jmg-2026-111509.

MLA (9th ed.) Citation

EK, Bijlsma, et al. "Reverse Haplotyping: Taking Full Advantage of 25% Risk Testing for the 50% At-risk Parent in Huntington's Disease." Journal of Medical Genetics, vol. 63, no. 7, 2026, p. 463, https://doi.org/10.1136/jmg-2026-111509.